Verdezyne’s Chief Scientific Officer to Receive Charles D. Scott Award

Stephen Picataggio to be Honored at the 33rd Symposium on Biotechnology for Fuels and Chemicals for His Contributions to the Industry

CARLSBAD, Calif.--()--Verdezyne, Inc., an industrial biotechnology company developing cost-effective processes for the production of renewable fuels and chemicals, announced today that Dr. Stephen Picataggio, chief scientific officer, will be presented with the Charles D. Scott Award on May 5, 2011, at the 33rd Symposium on Biotechnology for Fuels and Chemicals in Seattle, the premier meeting in its field.

The Charles D. Scott award acknowledges contributions to the field as a whole or to this Symposium, particularly innovation in fundamental and applied biotechnology, insight into bioprocessing fundamentals, or commitment to facilitate commercialization of products from renewable resources.

“We are extremely proud of Steve and his accomplishments in metabolic engineering and biotechnology,” said Dr. E. William Radany, president and CEO of Verdezyne. “He has been an invaluable asset to building and guiding our world-class yeast strain engineering platform.” Dr. Picataggio is a microbiologist with more than 25 years of experience engineering industrial microorganisms and developing fermentation processes for the production of renewable fuels and chemicals. At Verdezyne, he has established and leads programs on the metabolic engineering of industrial yeast strains for the production of cellulosic ethanol and adipic acid, the precursor for renewable nylon. Dr. Picataggio earned his BS in Bacteriology from Wagner College and Ph.D. in Microbiology from Rutgers University.

At the Symposium, Dr. Kirsty Salmon, director of renewable fuels, will be presenting on several breakthroughs in the development of proprietary xylose isomerases, while Dr. Thomas Beardslee, director of renewable chemicals, will present on the development of biobased adipic acid.

About Verdezyne

Verdezyne is an industrial biotechnology company using proven and proprietary metabolic pathway engineering tools to create unique yeast strains for cost-effective production of biobased fuels and chemicals. Current investors in Verdezyne include OVP Venture Partners, Monitor Ventures, Life Science Angels and Tech Coast Angels. For more information on Verdezyne, visit www.verdezyne.com.

Contacts

Schwartz Communications, Inc.
Jill Reed or Brianne Donahue, 415-817-2500
verdezyne@schwartzcomm.com

Sharing

Contacts

Schwartz Communications, Inc.
Jill Reed or Brianne Donahue, 415-817-2500
verdezyne@schwartzcomm.com